WuXi AppTec (OTCMKTS:WUXAY) Stock Price Down 7% – Here’s Why

WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY)’s share price was down 7% during trading on Friday . The company traded as low as $19.53 and last traded at $19.53. Approximately 144 shares were traded during mid-day trading, a decline of 93% from the average session volume of 2,174 shares. The stock had previously closed at $21.00.

Analyst Ratings Changes

Separately, Zacks Research raised shares of WuXi AppTec to a “hold” rating in a research report on Monday, April 13th. One equities research analyst has rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, WuXi AppTec currently has an average rating of “Moderate Buy”.

WuXi AppTec Trading Down 8.5%

The stock’s 50-day simple moving average is $17.46 and its 200 day simple moving average is $15.84.

WuXi AppTec (OTCMKTS:WUXAY) last posted its quarterly earnings data on Monday, April 27th. The company reported $0.23 earnings per share for the quarter, topping the consensus estimate of $0.18 by $0.05. The business had revenue of $1.82 billion during the quarter, compared to the consensus estimate of $1.59 billion.

WuXi AppTec Company Profile

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.